Startup Tenpoint Lands $70M to Bring Vision-Restoring Cell Therapy to the Eye
Tenpoint Therapeutics’ name refers to the time it takes for an image to hit the retina and be processed by the brain. The regenerative medicine startup is developing cell therapies it hopes restore that vision capability for patients with degenerative eye disorders.